e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Cystic fibrosis in the 21
st
century: cutting edge investigations, taxing problems
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Improved biomarkers of cystic fibrosis lung disease in bronchoalveolar lavage fluid identified using SELDI-TOF mass spectrometry
G. MacGregor, T. Hilliard, M. Imrie, J. A. Innes, A. C. Boyd, E. Alton, J. Davies, A. Bush, D. Porteous, A. P. Greening (Edinburgh, London, United Kingdom)
Source:
Annual Congress 2004 - Cystic fibrosis in the 21
st
century: cutting edge investigations, taxing problems
Session:
Cystic fibrosis in the 21
st
century: cutting edge investigations, taxing problems
Session type:
Oral Presentation
Number:
1355
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. MacGregor, T. Hilliard, M. Imrie, J. A. Innes, A. C. Boyd, E. Alton, J. Davies, A. Bush, D. Porteous, A. P. Greening (Edinburgh, London, United Kingdom). Improved biomarkers of cystic fibrosis lung disease in bronchoalveolar lavage fluid identified using SELDI-TOF mass spectrometry. Eur Respir J 2004; 24: Suppl. 48, 1355
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis-usual interstitial pneumonia (IPF-UIP) using SELDI-mass spectrometry
Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Year: 2007
Pulmonary transplantation and bronchiolitis obliterans syndrome: characterisation of diagnostic biomarkers in bronchioloalveolar lavage fluid by SELDI-TOF proteomic analysis
Source: Annual Congress 2009 - Bronchiolitis obliterans syndrome after lung transplantation: pathophysiology and treatment options
Year: 2009
Identification of four proteins from a "sarcoidosis-associated protein profile": SELDI-TOF MS analysis of bronchoalveolar lavage fluid (BALF)
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach
Source: Eur Respir J 2003; 21: 414-420
Year: 2003
Early detection of lung disease in cystic fibrosis
Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage
Year: 2007
Interstitial lung disease profiling by mean of broncho-alveolar lavage
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
Altered expression of bronchoalveolar lavage fluid proteins in sarcoidosis: A proteomics approach
Source: Eur Respir J 2003; 22: Suppl. 45, 449s
Year: 2003
Transcriptome analysis in endobronchial epithelial lining fluid compared to bronchoalveolar lavage in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Association between lobe specific bronchoalveolar lavage fluid metabolites and structural lung disease in young children with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015
SELDI-TOF biomarkers signatures for cystic fibrosis, asthma and COPD
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Proteomic profiling of peripheral blood and bronchoalveolar lavage fluid in interstitial lung diseases: an explorative study
Source: ERJ Open Res, 7 (1) 00489-2020; 10.1183/23120541.00489-2020
Year: 2021
The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease
Source: Eur Respir Rev 2010 19: 237-241
Year: 2010
Clinimetric properties of bronchoalveolar lavage inflammatory markers in cystic fibrosis
Source: Eur Respir J 2014; 43: 610-626
Year: 2013
Correlation between imaging fibrosis severity and bronchoalveolar lavage pattern in interstitial lung disease
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019
Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis
Source: Eur Respir J 2001; 17: 716-722
Year: 2001
The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases
Source: Eur Respir Mon; 2009: 46: 36–46
Year: 2009
ECP and EPX in bronchoalveolar lavage fluid in children with cystic fibrosis and mild lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 538s
Year: 2001
Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis
Source: Eur Respir J 2001; 17: 281-286
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept